AlphaGrep UK’s GeneDx Holdings WGS Stock Holding History

AlphaGrep UK’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-3,470	Closed	-$238K	–	960
2026 Q2	$238K	Buy	+3,470	New	+$197K	0.07%	614

Other funds holding WGS

ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

AlphaGrep UK's WGS Position: Q3 2026 in Review

AlphaGrep UK sold out of GeneDx Holdings (WGS) in Q3 2026, closing a stake of 3,470 shares — an estimated $238K sold.

AlphaGrep UK first reported a position in WGS in Q2 2026 and held it in 1 quarter. The position peaked at $238K in Q2 2026. 152 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

AlphaGrep UK reported no remaining GeneDx Holdings position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 3,470 GeneDx Holdings shares in Q3 2026, an estimated $238K.
AlphaGrep UK first reported a position in GeneDx Holdings in Q2 2026 and held it in 1 quarter.
AlphaGrep UK's GeneDx Holdings position peaked at $238K in Q2 2026.
152 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.